Pregnant women or nursing mothers or women of child-bearing potential not using adequate contraception

Patients with a history of long QT syndrome

Patients with Type I or uncontrolled Type II diabetes

Patients who have had a COPD exacerbation or respiratory tract infection within 6 weeks prior to screening

Patients with any history of asthma

Patients with pulmonary lobectomy, lung volume reduction surgery, or lung transplantation

Patients with concomitant pulmonary disease

Patients requiring long term oxygen therapy (\>15 h a day)

The Effect of QVA149 on Health Related Quality of Life in Patients With Chronic Obstructive Pulmonary Disease (COPD)